An ASNC Information Statement: Radiopharmaceutical supply disruptions and the use of 99mTc-hydroxymethylene diphosphonate as an alternative to 99mTc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis
Resource Type
Information Statements, Practice Points
Year Published
2022
Related Resources
Cases
PET Case: Perfusion Imaging Using Flurpiridaz F 18 PET
Case summary: This case illustrates the first clinical use of F-18 flurpiridaz…
Cases
PET Case: Cardiac PET in Apical HCM – A Case Series
Case summary: This case series illustrates the value of myocardial blood flow…
Cases
PET Case: Role of PET/CT Myocardial Perfusion Imaging in Post-Surgical Evaluation and Management of ALCAPA
Case summary: This case highlights the utility of PET myocardial perfusion imaging…
